Trinity Biotech Plc ADR (NASDAQ:TRIB) traded at $0.7 at close of the session on Tuesday, June 24 and made an upward move of 27.04% on its previous day’s price.
Looking at the stock we see that its previous close was $0.55 and the beta (5Y monthly) reads 0.81 with the day’s price range being $0.633 – $0.84. In terms of its 52-week price range, TRIB has a high of $3.44 and a low of $0.48. The company’s stock has lost about -5.41% over that past 30 days.
Trinity Biotech Plc ADR has a market cap of $13.01 million and is expected to release its quarterly earnings report on 2025-May-15.
On the other hand, looking at the outlook for the TRIB stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 9.68% off its SMA20 and 2.03% from its 50-day simple moving average. The RSI (14) is pointing at 55.44 while the volatility over the past week is 13.85% and jumps to 6.47% over the past one month.
Coming back to Trinity Biotech Plc ADR (NASDAQ:TRIB), we note that the average 3-month trading volume was 53.65K, while that of the preceding 10-day period stands at 4.39 million. Current shares outstanding are 18.59 million.
The insiders hold 0.10% of the company’s shares while institutions hold 4.32%. The data shows that short shares as of 2025-05-30, stood at 37686.0 at a short ratio of 0.53. This represents a 37.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 0.1 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -71.66% down in year-to-date price movement.
